The Short-Term Outcome of a Large Cohort of Very Preterm Infants Treated with Poractant Alfa (Curosurf®) for Respiratory Distress Syndrome: A Postmarketing Phase IV Study

Author： Lamboley-Gilmert G.   Lacaze-Masmonteil T.  

Publisher： Adis International

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.5, Iss.9, 2003-01, pp. : 639-645

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nitric oxide for the treatment of preterm infants with respiratory distress syndrome

By Dani Carlo   Pratesi Simone  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 1, 2013-01 ,pp. : 97-103

Informa Healthcare

Access to resources Recommend Favorite

Lucinactant for the prevention of respiratory distress syndrome in premature infants

By Jordan Brian K   Donn Steven M  

Expert Review of Clinical Pharmacology, Vol. 6, Iss. 2, 2013-03 ,pp. : 115-121

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Tolerability of Moxifloxacin in Patients with Respiratory Tract Infections Treated in General Practice: Results of a Post-Marketing Surveillance Study

By Chen Weiqiang   Wu Changgui   Li Zhikui   Bai Changqing  

Clinical Drug Investigation, Vol. 26, Iss. 9, 2006-01 ,pp. : 501-509

Adis International

Access to resources Recommend Favorite

Short-term dexamethasone can further reduce androgen levels in women with polycystic ovary syndrome treated with metformin

By  

Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of acute respiratory distress syndrome

By Santos CC dos   Slutsky AS   Chant C  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 875-888

Informa Healthcare

Access to resources Recommend Favorite